PGP9.5在咬合创伤大鼠颞下颌关节骨关节炎中作用的初步研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
目的:建立颞下颌关节骨关节炎大鼠模型,观察并评价大鼠颞下颌关节髁突软骨的组织学改变,检测PGP9.5在关节囊神经及髁突软骨中的表达及变化,并研究组织学改变与PGP9.5表达量之间的相关性,探讨PGP9.5在大鼠颞下颌关节骨关节炎中的作用,为临床上颞下颌关节紊乱病中骨关节炎的治疗提供一定的理论基础。
     方法:8周龄雌性Wistar大鼠60只(山东大学动物实验中心提供),体重200-250g,随机分为5个实验组(n=10)与1个对照组(n=10),通过在大鼠右上第一磨牙(?)面粘结正畸方丝造成咬合创伤,建立颞下颌关节骨关节炎模型。于建模后1、3、7、14、28d分批处死动物,取双侧颞下颌关节,制作石蜡切片,HE染色观察并评价髁突软骨的组织学改变;免疫组化染色检测PGP9.5在关节囊神经及髁突软骨中的表达;应用实时荧光定量PCR法检测关节囊神经及髁突软骨中PGP9.5mRNA的相对表达量。比较各实验组与对照组以及创伤侧与非创伤侧的各项指标之间的差别,并分析髁突组织学改变与PGP9.5表达量之间的相关性。
     结果:
     1)髁突组织学改变:HE染色显示各实验组大鼠髁突软骨发生不同程度的病理性改变,实验组Colombo关节软骨病理积分在6.32至18.35之间,颞下颌关节骨关节炎模型建立成功;实验组大鼠双侧Colombo关节软骨病理积分在1、3、7d逐渐升高,7d达到峰值,14、28d逐渐降低,其中3、7、14d创伤侧高于对照侧(p<0.05);3、7、14、28d实验组高于对照组(p<0.05),
     2)PGP9.5免疫组化染色平均光密度(optical density, OD)值:实验组大鼠双侧关节囊神经PGP9.5平均OD值在1、3、7d逐渐升高,7d达到峰值,14、28d逐渐降低,其中3、7d创伤侧高于对照侧(p<0.05);1、3、7d实验组高于对照组(p<0.05)。实验组大鼠双侧髁突软骨PGP9.5平均OD值在1、3、7d逐渐升高,7d达到峰值,14、28d逐渐降低,其中7、14d创伤侧高于对照侧(p<0.05);3、7、14d实验组高于对照组(p<0.05)。
     3) PGP9.5mRNA相对表达量:实验组大鼠双侧关节囊神经PGP9.5mRNA相对表达量在1、3d逐渐升高,7、14、28d逐渐降低,其中3、7d创伤侧高于对照侧(p<0.05);1、3、7d实验组高于对照组(p<0.05)。实验组大鼠双侧髁突软骨PGP9.5mRNA相对表达量在3d时出现明显升高,7、14、28d逐渐降低,其中1、3、7d创伤侧高于对照侧(p<0.05):1、3、7、14d实验组高于对照组(p<0.05)。
     4)相关性分析:髁突软骨PGP9.5平均OD值与Colombo关节软骨病理积分呈显著正相关(r=0.817,p<0.05)。
     结论:通过在大鼠右上第一磨牙(?)面粘结正畸方丝造成咬合创伤,可建立颞下颌关节骨关节炎模型。咬合创伤可引起大鼠颞下颌关节关节囊神经及髁突软骨中PGP9.5蛋白及mRNA的表达增高,且髁突软骨中PGP9.5表达量与Colombo关节软骨病理积分呈显著正相关,本研究为颞下颌关节紊乱病中骨关节炎的发病机制研究和治疗提供了新思路。
Objectives:To establish TMJ OA (tempromandibular join osteoarthritis) rat models, evaluate the histological changes of condylar cartilage, and investigate the expression of PGP9.5in the nerves of joint capsules and condylar cartilage. Explore the correlation between histological changes and PGP9.5expression, and discuss the roles PGP9.5plays in TMJ OA, in order to provide a theoretical basis for the treatment of TMJ OA.
     Methods:A total of608-week-old female Wistar rats (provided by the Experimental Animal Center of Shandong University), weighing200-250g, were randomly divided into one control group (n=10) and five experimental groups (n=10). TMJ OA rat models were established by bonding an orthodontic square wire on the occlusal surface of the right first maxillary molar to create occlusal trauma. The TMJs were prepared for HE, immunohistochemical staining and real-time PCR analysis at1,3,7,14and28days after teeth operation. Compare the histological changes and PGP9.5expression between the experimental groups and the control group, and between the traumatic sides and the non-traumatic sides of experimental groups; analyze the correlation between histological changes and PGP9.5expression.
     Results:
     1) Histological changes of condylar cartilage:OA-like lesions were induced in the experimental group rats, with the Colombo histological scores ranging from6.32to18.35in different groups, which indicated that the TMJ OA models were established successfully. The Colombo histological scores of the experimental groups gradually rose on the1st,3rd and7th days, and reached the peak on the7th day before decreasing by the14th and28th days. The scores of experimental groups were significantly higher than those of the control group on the1st,3rd,7th and14th days (p<0.05). The scores of traumatic sides were significantly higher than those of the non-traumatic sides on the3rd,7th and14th days (p<0.05).
     2) PGP9.5mean OD value:The PGP9.5mean OD value of the nerves of joint capsules gradually rose on the1st,3rd and7th days, reaching the peak on the7th day, and then decreasing by the14th and28th days. The mean OD of experimental groups were significantly higher than those of the control group on the1st,3rd and7th days (p<0.05). The mean OD of traumatic sides were significantly higher than those of the non-traumatic sides on the3rd and7th days (p<0.05). The PGP9.5mean OD value of condylar cartilage gradually rose on the1st,3rd and7th days, reaching the peak on the7th day, and then decreasing by the14th and28th days. The mean OD of experimental groups were significantly higher than those of the control group on the3rd,7th and14th days (p<0.05). The mean OD of traumatic sides were significantly higher than those of the non-traumatic sides on the7th and14th days (p<0.05).
     3) The expression of PGP9.5mRNA:The expression of PGP9.5mRNA of the nerves of joint capsules gradually rose on the1st and3rd days, and then decreasing by the7th,14th and28th days (p<0.05). The mRNA expression of experimental groups were significantly higher than those of the control group on the1st,3rd and7th days (p<0.05). The mRNA expression of traumatic sides were significantly higher than those of the non-traumatic sides on the3rd and7th days (p<0.05). The expression of PGP9.5mRNA of condylar cartilage gradually rose on the1st and3rd days, and then decreasing by the7th,14th and28th days (p<0.05). The mRNA expression of experimental groups were significantly higher than those of the control group on the7th,14th and28th days (p<0.05). The mRNA expression of traumatic sides were significantly higher than those of the non-traumatic sides on the1st,3rd, and7th days (p<0.05).
     4) Correlation analysis:A positive correlation exists between PGP9.5mean OD and Colombo histological scores of condylar cartilage (r=0.817,p<0.05).
     Conclusions:Experimentally created traumatic occlusion can induce obvious TMJ OA-like lesions. Traumatic occlusion was found to raise the expression of PGP9.5and PGP9.5mRNA in the nerves of joint capsules and condylar cartilage. In addition, a positive correlation exists between PGP9.5expression and Colombo histological scores of condylar cartilage. Therefore, new ideas for etiological mechanism study and clinical treatment of TMJ OA were provided.
引文
[1]马绪臣.颞下颌关节病的基础与临床[M].北京:人民卫生出版社,2000:102-107.
    [2]洪宇娟.颞下颌关节骨关节病动物模型的建立及其病理机制的实验研究[D].四川大学,2005.
    [3]Heijink A, Gomoll AH, Madry H, Drobnic M, Filardo G, et al. Biomechanical considerations in the pathogenesis of osteoarthritis of the knee [J]. Knee Surg Sports Traumatol Arthrosc,2012,20:423-435.
    [4]Holmlund A, Ekblom A, Hansson P, et al. Concentrations of neuropeptides substance P, neurokinin A, calcitonin gene-related peptide, neuropeptide Y and vasoactive intestinal polypeptide in synovial fluid of the human temporomandibular joint. A correlation with symptoms, signs and arthroscopic findings [J]. Int J Oral Maxillofac Surg,1991, 20(4):228-231
    [5]Wilkinson KD, Lee KM, Deshpande S, Duerksen-Hughes P, Boss JM, Pohl J. The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase [J]. Science, 1989,246(4930):670-673.
    [6]Xiang T, Li L, Yin X, Yuan C, Tan C, et al. The ubiquitin peptidase UCHL1 induces G0/G1 cell cycle arrest and apoptosis through stabilizing p53 and is frequently silenced in breast cancer [J]. PLoS One,2012,7(1):e29783.
    [7]Kwon J, Wang YL, Setsuie R, Sekiguchi S, Sato Y, et al. Two closely related ubiquitin C-terminal hydrolase isozymes function as reciprocal modulators of germ cell apoptosis in cryptorchid testis [J]. Am J Pathol,2004,165(4):1367-1374.
    [8]Aroni K, Grapsa A, Lazaris AC, Kavantzas N, Kordosis T, Patsouris ES. Tissue estimation of protein gene product 9.5 (PGP 9.5) expression and apoptosis in vitiligo [J]. Int J Dermatol,2008,47(9):911-917.
    [9]Kitamura, H.P., Yanase, H., Kitamura, H., Iwanaga, T. Unique localization of protein gene product 9.5 in type B synoviocytes in the joints of the horse [J]. J Histochem Cytochem,1999,47(3):343-352.
    [10]Martel-Pelletier J, Boileau C, Pelletier JP, et al. Cartilage in normal and osteoarthritis conditions [J]. Best Pract Res Clin Rheumatol,2008,22(2):351-384.
    [11]秦霞南,龙星,李金荣,等.颞下颌关节骨关节病临床病理研究[J].口腔医学研究,2005,21(4):440442.
    [12]Lekkas C, Honee GL, van den Hooff A. Effects of experimental defects of the articular disc of the temporomandibular joint in rats [J]. J Oral Rehabil,1988, 15(2):141-148.
    [13]Meng JH, Ma XC, Li ZM, et al. Aquaporin-1 and aquaporin-3 expressions in the temporo-mandibular joint condylar cartilage after an experimentally induced osteoarthritis [J]. Chin Med J,2007,120(24):2191-2194.
    [14]满城,张碧,马永清,等.关节腔注射TGF—1治疗兔颞下颌关节骨关节炎的实验研究[J].临床口腔医学杂志,2009,12(25):589-592.
    [15]Ishimaru J, Goss AN. A model for osteoarthritis of the temporomandibular joint [J]. J Oral Maxillofac Surg,1992,50(11):1191-1195.
    [16]van Osch GJ, van der Kraan PM, van den Berg WB. Site specific inhibition of cartilage proteoglycan synthesis in the murine knee joint. Differences between 3 metabolic stimuli [J]. J Rheumatol,1994,21(6):1107-1112.
    [17]Guingamp C, Gegout-Pottie P, Philippe L, et al. Mono-iodoacetate-induced experimental osteoarthritis, a dose-response study of loss of mobility, morphology and biochemistry [J]. Arthritis Rheum,1997,40(9):1670-1679.
    [18]Cledes G, Felizardo R, Foucart JM, Carpentier P. Validation of a chemical osteoarthritis model in rabbit temporomandibular joint:a compliment to biomechanical models [J]. Int J Oral Maxillofac Surg.2006,35(11):1026-1033.
    [19]Dijkstra PU, Kropmans TJ, Stegenga B, et al. The association between generalized joint hypermobility and temporomandibular joint disorders:a systematic review [J]. J Dent Res,2002,81(3):158-163.
    [20]Fujisawa T, Kuboki T, Kasai T, et al. A repetitive, steady mouth opening induced an osteoarthritis-like lesion in the rabbit temporomandibular joint[J]. J Dent Res,2003, 82(9):731-735.
    [21]EI-Hakim IE, Elyamani AO. Preliminary evaluation of histological changes found in a mechanical arthropatic temporomandibular joint (TMJ) exposed to an intra-articular Hyaluronic acid (HA) injection, in a rat model [J]. J Craniomaxillofac Surg,2011, 39(8):610-614.
    [22]周月珠,雷蕾,倪国新.SLRPs在骨性关节炎发病中的作用[J].医学综述,2012,18(17):2768-2770.
    [23]Ameye L, Young MF. Mice deficient in small leucine-rich proteoglycans:novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases [J]. Glycobiology,2002,12(9):107-116.
    [24]Jepsen KJ, Wu F, Peragallo JH, et al. A syndrome of joint laxity and impaired tendon integrity in lumican-and fibromodulin-deficient mice [J]. J Biol Chem,2002, 277(38):35532-35540.
    [25]Ameye L, Aria D, Jepsen K, et al. Abnormal collagen fibrils in tendons of biglycan/fibromodulin-deficient mice lead to gait impairment, ectopic ossification, and osteoarthritis [J]. FASEB J,2002,16(7):673-680.
    [26]Nuka S, Zhou W, Henry SP, et al. Phenotypic characterization of epiphycan-deficient and epiphycan/biglycan double-deficient mice [J]. Osteoarthritis Cartilage,2010, 18(1):88-96.
    [27]Wang GW, Wang MQ, Wang XJ, et al. Changes in the expression of MMP-3, MMP-9, TIMP-1 and aggrecan in the condylar cartilage of rats induced by experimentally created disordered occlusion [J]. Arch Oral Biol,2010,55(11):887-895.
    [28]杨红岩,刘继光,王本才,等.咬合创伤兔颞下颌关节的组织学变化的实验研究[J].黑龙江医药科学,2007,30(3):42-43.
    [29]Doran JF, Jackson P, Kynoch PA, Thompson RJ. Isolation of PGP 9.5, a new human neurone-specific protein detected by high-resolution two-dimensional electrophoresis [J]. JNeurochem,1983,40(6):1542-1547.
    [30]Satoh JI, Kuroda Y. Ubiquitin C-terminal hydrolase-L1 (PGP 9.5) expression in human neural cell lines following induction of neuronal differentiation and exposure to cytokines, neurotrophic factors or heat stress [J]. Neuropathol Appl Neurobiol.2001, 27(2):95-104.
    [31]Krammer HJ, Karahan ST, Rumpel E, Klinger M, Kuhnel W. Immunohistochemical visualization of the enteric nervous system using antibodies against protein gene product (PGP) 9.5 [J]. Ann Anat.1993,175(4):321-325.
    [32]Hsieh ST, Lin WM, Chiang HY, Huang IT, Ko MH, et al. Skin innervation and its effects on the epidermis [J]. J Biomed Sci,1997,4(5):264-268.
    [33]Hasan W, Cowen T, Barnett PS, Elliot E, et al. The sweating apparatus in growth hormone deficiency, following treatment with r-hGH and in acromegaly [J]. Auton Neurosci,2001,89(1-2):100-109.
    [34]Loo LS, Ng YK, Zhu YZ, Lee HS, Wong PT. Cortical expression of endothelin receptor subtypes A and B following middle cerebral artery occlusion in rats [J]. Neuroscience,2002,112(4):993-1000.
    [35]凌丽,薛金伟.神经纤维标记物-蛋白基因产物9.5(PGP 9.5)的研究概况[J].中国老年学杂志,2010,30(21):3226-3228.
    [36]王国坤,田风霞,宫江峰,王玮.泛素/26S蛋白酶体系统介导的细胞程序化死亡[J].生命科学,2011,23(1):26-31.
    [37]Li L, Tao Q, Jin H, van Hasselt A, Poon FF, et al. The tumor suppressor UCHL1 forms a complex with p53/MDM2/ARF to promote p53 signaling and is frequently silenced in nasopharyngeal carcinoma [J]. Clin Cancer Res,2010,16(11):2949-2958.
    [38]Bheda A, Yue W, Gullapalli A, et al. Positive reciprocal regulation of ubiquitin C-terminal hydrolase L1 and beta-catenin/TCF signaling [J]. PLoS One,2009, 4(6):e5955.
    [39]安良,高亚,王晓伟.RT-PCR检测肿瘤标志物PGP 9.5 [J]陕西医学检验,1996,11(4):23-24.
    [40]Shono K, Tajiri T, Fujii Y, Suita S. Clinical implications of minimal disease in the bone marrow and peripheral blood in neuroblastoma [J]. J Pediatr Surg,2000, 35(10):1415-1420.
    [41]Hibi K, Westra WH, Borges M, Goodman S, Sidransky D, Jen J. PGP 9.5 as a candidate tumor marker for non-small-cell lung cancer [J]. Am J Pathol,1999, 155(3):711-715.
    [42]Sasaki H, Yukiue H, Moriyama S, Kobayashi Y, Nakashima Y, et al. Expression of the protein gene product 9.5, PGP 9.5, is correlated with T-status in non-small cell lung cancer [J]. Jpn J Clin Oncol,2001,31(11):532-535.
    [43]Brichory F, Beer D, Le Naour F, Giordano T, Hanash S. Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer [J]. Cancer Res,2001,61(21):7908-7912.
    [44]张弦,张小兵,陶凯雄,等.人胃癌PGP9.5的表达及其临床意义[J].中国普外基础与临床杂志,2007,14(1):76-79.
    [45]张小兵,陶凯雄,张弦,等.PGP9.5在结直肠癌进展中的表达及其临床意义[J].实用医学杂志,2006,22(19):2238-2239.
    [46]Takano T, Miyauchi A, Matsuzuka F, Yoshida H, et al. PGP 9.5 mRNA could contribute to the molecular-based diagnosis of medullary thyroid carcinoma [J]. Eur J Cancer,2004,40(4):614-618.
    [47]Takase T, Hibi K, Yamazaki T, Nakayama H, Taguchi M, et al. PGP 9.5 overexpression in esophageal squamous cell carcinoma [J]. Hepatogastroenterology, 2003,50(53):1278-1280.
    [48]Lee YM, Lee JY, Kim MJ, Bae HI, Park JY, et al. Hypomethylation of the protein gene product 9.5 promoter region in gallbladder cancer and its relationship with clinicopathological features [J]. Cancer Sci,2006,97(11):1205-1210.
    [49]Yamazaki T, Hibi K, Takase T, et al. PGP 9.5 as a marker for invasive colorectal cancer [J]. Clin Cancer Res,2002,8(1):192-195.
    [50]Colombo C, Butler M, O'Byrne E, Hickman L, Swartzendruber D, et al. A new model of osteoarthritis in rabbits. Ⅰ. Development of knee joint pathology following lateral meniscectomy and section of the fibular collateral and sesamoid ligaments [J]. Arthritis Rheum,1983,26(7):875-886.
    [51]Schmidt BL, Pogrel MA, Necoechea M, et al. The distribution of the auriculotemporal nerve around the temporomandibular joint [J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod,1998,86(2):165-168.
    [52]Li J, Ahmad T, Spetea M, Ahmed M, et al. Bone reinnervation after fracture:a study in the rat [J]. J Bone Miner Res,2001,16(8):1505-1510.
    [53]Poulsen TT, Naizhen X, Poulsen HS, et al. Acute damage by naphthalene triggers expression of the neuroendocrine marker PGP 9.5 in airway epithelial cells [J]. Toxicol Lett,2008,181(2):67-74.
    [54]Ikeuchi M, Kolker SJ, Burnes LA, et al. Role of ASIC3 in the primary and secondary hyperalgesia produced by joint inflammation in mice [J]. Pain,2008,137(3):662-669.
    [55]Kwon J. The new function of two ubiquitin C-terminal hydrolase isozymes as reciprocal modulators of germ cell apoptosis [J]. Exp Anim,2007,56(2):71-77.
    [56]Nakajima T, Murabayashi C, Ogawa K, Taniguchi K. Immunoreactivity of protein gene product 9.5 (PGP 9.5) in the developing hamster olfactory bulb [J]. Anat Rec, 1998,250(2):238-244.
    [57]Esteve-Rudd J, Campello L, Herrero MT, Cuenca N, Martin-Nieto J. Expression in the mammalian retina of parkin and UCH-L1, two components of the ubiquitin-proteasome system [J]. Brain Res,2010,1352:70-82.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700